NeurogesX and Astellas Enter into Commercialisation Agreement for Pain Patch
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 7 (Table of Contents)
Published: 8 Jul-2009
DOI: 10.3833/pdr.v2009.i7.1132 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
NeurogesX and Astellas Pharma entered into an exclusive distributive, marketing and licensing agreement for the commercialisation of Qutenza™ (capsaicin) in Europe, Middle East and Africa...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS